WHO ICTRP trial
A study comparing Remifentanil and Lidocaine as interventions to control Blood…
CTRI/2025/11/097306 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/11/097306 |
|---|---|
| Public title | A study comparing Remifentanil and Lidocaine as interventions to control Blood Pressure and Heart Rate during Intubation in study participants, with the main outcome being how effectively they keep these vital signs stable |
| Scientific title | Comparison of Remifentanil and Lidocaine in attenuation of haemodynamic responses during intubation in patients undergoing general anesthesia - Nil |
| Primary sponsor | ESIC Medical College and Hospital |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: O- Medical and Surgical |
| Interventions | Intervention1: Injection REMIFENTANIL: One dose of INJ REMIFENTANIL 1mcg/kg Intravenously will be injected 90 seconds before intubation Control Intervention1: INJ LIDOCAINE: One dose of INJ LIDOCAINE 1mg/kg Intravenously injected 90 seconds… |
| Registration date | Nov 13, 2025 |
| Target size | 60 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: